Search Results

Showing results 1 - 10 of 2032.
Sort By: Date ▼

PBMs pass on nearly 100% of rebates to Medicare Part D plans, GAO finds

August 19, 2019


Pharmacy benefit managers in 2016 passed on nearly all of the rebates they negotiated with pharmaceutical companies for Medicare Part D drugs to insurers sponsoring Part D plans, resulting in lower premiums for such plans, according to a Government Accountability Office report released Wednesday.

In the states: AMA leaves group that opposes 'Medicare for All,' shots fired at an Illinois VA hospital, and more

August 16, 2019


American Health Line rounds up the latest health care news in the states.

FDA approves drug that could be a 'breakthrough' for patients with antibiotic-resistant TB

August 15, 2019


FDA on Wednesday approved a new antibiotic, called pretomanid, to treat highly drug-resistant strains of tuberculosis, which kills about 500,000 of the 1.6 million individuals who die annually from the infectious disease.

Are big employers on board with ‘Medicare for All’?

August 15, 2019


A survey by the National Business Group on Health of 147 large employers that cover more than 15.6 million people revealed that employers are sharply divided on so-called “Medicare-for-All” proposals—and are planning to implement their own ideas to lower health care costs.

Drugmakers and health systems are sharing your genetic data. Here's why.

August 15, 2019


Drugmakers and health systems are entering into agreements to share patients' genetic information for research purposes—but these sometimes-exclusive deals are attracting pushback from some ethics and privacy experts.

Are we nearing an Ebola cure? 2 new treatments dramatically improve survival.

August 14, 2019


Health officials on Monday announced that two experimental treatments appear to have improved the survival rates of patients infected with the Ebola virus, and the treatments now will be offered to all patients in the Democratic Republic of Congo who have contracted the virus.

Where you live could determine how your heart attack is treated

August 14, 2019


A patient's geographic region is strongly correlated with whether he or she receives a high-intensity statin after a heart attack, according to a study recently published in JAMA Cardiology.

An immune-disorder drug is in a shortage. Here’s how it's affecting patients.

August 13, 2019


U.S. hospitals and infusion clinics are rationing a medicine approved to treat immune disorders and suspending treatment for many patients who use the drug amid a nationwide shortage.

Why an iron infusion could cost $412—or $4,316

August 12, 2019


Experts say the common brand-name products used for IV iron infusions in many cases are medically interchangeable—yet providers increasingly are administering the most costly products, leaving patients facing unexpectedly high bills.

Can 'authorized generics' actually raise Rx prices?

August 12, 2019


Drugmakers increasingly are creating generic versions of their own brand-name drugs, aiming in part to sustain revenue after patents expire, but some critics say these so-called "authorized generics" stifle competition and ultimately could increase prices.

Results Page: [Previous] 1 2 3 4 5  ... [Next]